Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Mar. 31, 2019	Jun. 30, 2018
Current assets:
Cash	$ 33,916	$ 42,121
Accounts receivable, net	375,970	453,623
Inventory, net	627,369	531,249
Loan receivables	191,776	157,872
Other current assets	2,099,634	756,565
Total current assets	3,328,665	1,941,432
Equipment, net	450,852	195,180
Intangible Asset	11,550	12,600
Other assets	68,751	38,751
Total Assets	3,859,818	2,187,963
Current liabilities:
Note payable due to bank	25,982	25,982
Accounts payable and accrued liabilities	1,368,547	1,707,641
Customer deposits	310,128	329,509
Unearned revenue	65,013	110,142
Other payable	367,239	241,771
Accrued interest	448,942	493,365
Accrued compensation and personnel related payables	24,528	869,673
Note Payable	20,000	20,000
Notes payable - related parties	18,000	23,000
Loans payable	190,755	329,029
Loans payable - related party	30,000	30,000
Convertible notes payable, net	1,059,655	2,399,941
Derivative liabilities	2,541,563	3,069,616
Warrants liabilities	39,192	40,400
Shares to be issued	50,000	2,691,000
Total current liabilities	6,559,544	12,381,069
Total liabilities	6,559,544	12,381,069
Stockholders' deficiency:
Preferred stock ($0.001 par value, 10,000,000 shares authorized, 2,000,000 and 0 issued and outstanding at March 31, 2019 and June 30, 2018, respectively)	2,000
Common stock ($0.001 par value, 1,990,000,000 shares authorized, 660,473,827 and 246,135,203 shares issued and outstanding at March 31, 2019 and June 30, 2018, respectively)	660,474	246,136
Additional paid-in capital	59,550,187	21,952,560
Shares issued advance for Investment	(18,000,000)
Shares to Be Issued, Preferred Shares		2,000,000
Shares to Be Issued, Common Shares		467,996
Accumulated deficiency	(44,912,387)	(34,859,799)
Total stockholders' equity (deficiency)	(2,699,726)	(10,193,106)
Total liabilities and stockholders' equity (deficiency)	$ 3,859,818	$ 2,187,963